Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
clinicaltrials.gov TREASURE update:
Last Update Posted: February 20, 2018
Actual Study Start Date: November 15, 2017
Estimated Primary Completion Date: March 2020
Estimated Study Completion Date: December 2020
https://clinicaltrials.gov/ct2/show/NCT02961504
Fox26 story: Stem cells may successfully treat stroke symptoms
http://www.fox26houston.com/health/stem-cells-may-successfully-treat-stroke-symptoms
Video: https://www.facebook.com/MelissaWilsonFOX26/videos/1613261992070573
Stem cell trial aims to provide new therapy for stroke patients
http://chronicle.augusta.com/news/health/2016-10-05/stroke-therapy-targeted-stem-cell-trial?v=1475643198#
http://m.chronicle.augusta.com/news/health/2016-10-05/stroke-therapy-targeted-stem-cell-trial#gsc.tab=0
Note that it's some "per share prices", not some shares.
Thanks, Louisa! (The conference is in Singapore of course).
Status Conference scheduled for July 17, 2012.
http://investorstemcell.com/forum/rockys-corner/6456-101.htm#post86838
Note that the date Google Finance shows for PINK:ACTC is Mar 31. So I believe it's nothing but a glitch.
Yes, it's a 10-year-old article:
http://www.dailymail.co.uk/home/search.html?sel=site&searchPhrase=Kidney+breakthrough
I believe there is. This was posted on I-CELL two months ago:
sent this question to ACTC IR - for what its worth:
Is ACT in active communication with the NIH regarding the definition change? Has this become a dead issue driven by the current political climate?
Reply
We have been in regular dialogue with them. As you may know, the guidelines were previously published for public comment, but now the NIH is thinking of making additional definitional changes. We are trying to get them to publish the already-reviewed language and then perhaps to make an amendment later, but we are waiting to hear from them.
http://investorstemcell.com/forum/stemcell-news/7610.htm#post34291
Answer: No one. It's just an automated glitch.
There is a reason for this drop. I suggest you read Rocky's post and the posts that follow it on ICELL:
http://investorstemcell.com/forum/act-sec-documents-legal-matters-patents/7479-11.htm#post37690
Thanks , louisa! I see this video for the first time. I coppied the link and posted it on ICELL:
http://investorstemcell.com/forum/act-main-forum-general-topics-science-press-releases-media/7467.htm#post33966
S. Korea to invest 90 mln USD in stem cell research
SEOUL, Sept. 19 (Xinhua) -- South Korea will invest some 100 billion won (90 million U.S. dollars) in stem cell research next year to boost what it sees as a "core new growth engine," President Lee Myung-bak said Monday.
Stem cell research here has been put on the back burner since Hwang Woo-suk, the country's once-idolized cloning researcher, was found to have fabricated his research findings.
"While we were faltering in our quest for stem cell research, other nations streamlined their regulations and aggressively expanded their investments in research," Lee said in his biweekly radio speech, referring to the Hwang debacle "a disappointing incident" that "caused inevitable damage to the entire stem-cell research community" in South Korea.
The government will increase investment into stem cell research efforts and help turn the industry into a new key "growth engine" of the domestic economy following the IT industry, Lee said in the address to the public.
The president also pledged to establish a "national stem cell bank" to "produce, preserve and supply" stem cells to researchers and establish a new system aimed at facilitating clinical and licensing procedures.
The government will also rectify elements that "impede commercialization" of stem cell research, Lee added.
The speech came after the president met with a group of stem cell research firms and government officials last week and vowed to increase budget for research and development efforts in the field.
http://news.xinhuanet.com/english2010/health/2011-09/19/c_131146721.htm
_______________________________________________________________
South Korea sets sights on becoming stem cell powerhouse, again
Sun, Sep 18 2011
By Jeremy Laurence
SEOUL (Reuters) - South Korea's president vowed on Monday a series of regulatory reforms to help regain its place as a stem cell research powerhouse, trying to reclaim momentum five years after a cloning scandal.
President Lee Myung-bak said that by breathing new life into the industry, it could become "core new growth engine" for Asia's fourth biggest economy along the same lines as its lucrative IT sector.
"Just a decade ago, Korea took the lead in stem cell research in the world along with the United States," Lee said in a bi-weekly radio address.
"Unfortunately, there was a disappointing incident, which caused inevitable damage to the entire stem-cell research community in Korea," Lee said, referring to the scandal involving the pre-eminent scientist, Hwang Woo-suk.
South Korea had once been considered a global leader in human embryonic stem cell research until review boards said in 2005 that the team led by Hwang had manipulated key data in its studies on cloning stem cells, sparking a fraud case that shook the global scientific community.
As a result of the scandal, South Korea all but put stem cell research into the deep freeze.
Lee said the lapse had allowed other countries such as the United States, Japan, Britain and China to get the jump on South Korea, depriving the country of valuable revenue.
"While we were faltering in our quest for stem cell research, other nations streamlined their regulations and aggressively expanded their investments in research," he said.
"CORE GROWTH ENGINE"
Lee said the government would invest nearly 100 billion won ($90 million) in stem cell research next year and that it would reform related regulations to make clinical and licensing procedures easier.
He said the reforms would help the Korea Food and Drug Administration (KFDA) and other agencies "to ensure that they proactively adapt to the changes in the international environment".
"The government has decided to foster the stem cell industry as a core new growth engine following the footsteps of the IT industry," he said.
Stem cells are the body's master cells and the source of all cells and tissues. Because of their ability to generate different types of cells and multiply and self-renew, scientists hope to harness them to treat a variety of diseases and disorders, including cancer and diabetes, and injuries.
Stem cell research is "very rewarding and significant in that it can give hope to those who suffer from rare and intractable diseases," Lee said.
"In addition, from a business perspective, it can be said to be a high-value-added industry.
"This field is new and offers infinite room for advancement, and how well we manage at this initial stage will make an enormous difference down the road. The country should now set its eyes on emerging as a stem cell powerhouse."
The government will create a national stem cell bank for use to produce, preserve and supply stem cells to various researchers in the country on a stable basis, Lee added.
In July, the KFDA approved stem cell medication in the form of a treatment for heart attack victims for the world's first clinical use.
That Hearticellgram-AMI treatment, developed by FCB-Pharmicell, signaled the country's first salvo to put research in the field back on the frontline.
http://www.reuters.com/assets/print?aid=USTRE78I0DM20110919
It was said about efficacy (plus safety).
If it's safe but not efficient, it's worthless.
Thanks, Twaro. Of course I read it but forgot.
It seemes that you are right about the electronic equipment.
From the proxy: "Cameras, recording devices, and other electronic devices will not be permitted at the meeting."
http://yahoo.brand.edgar-online.com/EFX_dll/EDGARpro.dll?FetchFilingHTMLSection1?SessionID=v1EaHeDu1WH0Xz7&SectionID=7922372-1149-115666
Are you sure about the webcast? (I haven't seen this mentioned anywhere).
Thanks. Here is another report:
Fresh Embryos 2011-04-18
The government has received application requesting approval for research on creating patient-specific stem cells using “fresh” embryos instead of frozen ones for the first time in the country. Whether the government will grant approval is attracting attention.
The request was filed by the Cha Medical Center and the decision will be made by the National Bioethics Committee on April 27th.
Stem Cell
Stem cells are also called pluripotent cells, which are cells that can be developed into any specialized cells in the body. Stem cells are mainly collected from embryos in the early cell division process. Cells in this stage are not capable of developing into organs so they can be raised into specific cell lines. In this light, stem cells are considered the basic unit of life. The manipulation of stem cells can be a miracle technology to cure terminal diseases but it can also become a disastrous ability of tinkering with human life. Embryonic stem cells which are extracted from early stage embryos come from fertilized eggs. Cells are created when the fertilized egg grows into an embryo in the uterus. Embryonic stem cells have the ability to differentiate into any human cell.
Fresh Embryo
In the request, the Cha Medical Center has asked for taking out a single blastomere from 4-cell embryos after more than two days since fertilization to grow it into multiple cells. The cells will be used for pre-implantation genetic testing and leftover cells will be made into stem cell lines. Genetic testing before implantation enables finding out the baby’s gender beforehand and discovery of any genetic defects. It also secures stem cells. Researchers are upbeat about the positive effects. The problem is the use of “fresh” embryos which are fertilized eggs before they are implanted in the womb. Scholars of ethics believe human life begins from this stage onward. Korean law allows research using frozen embryos (embryos that have passed the five year preservation period) but bans the use of fresh embryos.
[ Dispute research using fresh embryos ]
Researchers: Stem cells leftover after being used for genetic test purposes are thrown away anyways. We ask approval to use them for research.
Critics: The stem cells, also derived from fertilized embryos, should not be used to create cell lines.
Gov’t: A deliberation team at the Korea Centers for Disease Control and Prevention has failed to reach a decision on this matter. During deliberation by an expert panel of the Health Ministry on Thursday, objections outweighed support but a conclusion was not reached. A decision will be finalized by the National Bioethics Committee on Apr. 27.
http://rki.kbs.co.kr/english/news/news_newissue_detail.htm?No=2540
I believe that this is the video of Dr. Lanza that you are looking for:
ASTM's upgrade is probably not the reason. It didn't affect the whole stem cells sector:
GERN up only 1.24%
STEM up only 0.35%
It's $50 million, and will be given to 4 companies at the most.
You can read it here:
http://californiastemcellreport.blogspot.com/2011/02/four-firms-seeking-50-million-from.html
Just to be precise, I think that Lanza spoke about "the comimg weeks" and not "several weeks".
ASTM is halted, for news pending, not ACTC.
Thank you!
And this is the full PR text:
http://www.estools.eu/estools/news/latest/Press-release-17-May-2010
Which refers to the full article text:
http://www.cell.com/cell-stem-cell/fulltext/S1934-5909(10)00160-8
You can organize it by "Date Submitted":
http://grants.nih.gov/stem_cells/registry/pending.htm?sort=dta